GlaxoSmithKline has hired a trio of banks to help it orchestrate a spinoff for the HIV-focused venture it majority-owns, Reuters reports, part of a companywide reorganization effort.

…read more

Source: Report: GlaxoSmithKline moves toward an IPO for its HIV business